17/12/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

17/12/2024

Dec 17, 2024, 13:45 | Blog
Highlights from IASLC HTTR 2024 by Stephen V Liu
HHTR 2024 took place from December 13-15, 2024, at the Hilton Washington DC National Mall…
Dec 17, 2024, 13:40 | Insight
Anita Hjelmeland is the recipient of the AACR-Novocure Cancer Research Grants 2024
Anita Hjelmeland is one of the recipients of the 2024 AACR-Novocure Cancer Research Grants. She…
Dec 17, 2024, 13:36 | Blog
Secure Your Spot for the "CancerX Continuity and 2025 Planning" Webinar
CancerX shared a post on LinkedIn: "48 Hours to Go – Register Now!! Secure Your…
Dec 17, 2024, 13:33 | Blog
Barriers and facilitators of Hispanic/Latino parents caregiving for a childhood cancer survivor - Train at NCI
Train at NCI shared a post on LinkedIn: "Join us for the next virtual NCI…
Dec 17, 2024, 13:22 | Science
A summary of important studies in breast cancer from 2024 by Yakup Ergün
Yakup Ergün, Medical Oncologist at Antalya City Hospital, posted on X: "What happened in breast…
Dec 17, 2024, 13:03 | Insight
Abstract submissions are open for POEM 4th Scientific Meeting
Abstract submissions are now open for upcoming POEM 4th Scientific Meeting planned to be held…
Dec 17, 2024, 12:59 | Insight
Highlights from IASLC HTTR 2024
HHTR 2024 took place from December 13-15, 2024, at the Hilton Washington DC National Mall…
Dec 17, 2024, 12:56 | Science
Anna Obenauf: Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
Anna Obenauf, Group Leader at IMP Vienna, shared her recent article on X: "Thrilled to…
Dec 17, 2024, 12:35 | Blog
Cancer Research Communications - Variant of uncertain VUS patterns among patients with early-onset colorectal cancer
Cancer Research Communications shared on X: "Recently published: Variant of uncertain significance VUS patterns among…
Dec 17, 2024, 10:00 | Dialogues
Invest in Health Policy: A Conversation with Professor Andreas Charalambous
In an engaging discussion with OncoDaily, Professor Andreas Charalambous, a globally recognized leader in oncology…
All: 83 Posts: 51 - 60
Special Coverage